Spectrophotometric and column high-performance liquid chromatographic methods for simultaneous estimation of metoprolol tartrate and hydrochlorothiazide in tablets.
Simple, accurate, economical, and reproducible UV spectrophotometric and column high-performance liquid chromatographic (HPLC) methods were developed for simultaneous estimation of a 2-component drug mixture of metoprolol tartrate and hydrochlorothiazide in combined tablet dosage form. The first method used the simultaneous equation method with 7 mixed standards and the absorption maxima at 223 and 271 nm, respectively, for metoprolol tartrate and hydrochlorothiazide in methanol. Linearity was observed in the concentration ranges of 4-24 and 2-16 microg/mL for metoprolol tartrate and hydrochlorothiazide, respectively. The developed HPLC method used a reversed-phase C18 column and methanol-water (95 + 5) mobile phase at an ambient temperature of 27 +/- 2 degrees C and UV detection at 225 nm; the run time was 10 min, and quantification was based on peak area. The injection repeatability and intraday and interday repeatability were calculated. Paracetamol was used as an internal standard for the HPLC method, and linearity was observed in the concentration range of 5-50 microg/mL for metoprolol and 2-20 microg/mL for hydrochlorothiazide. The proposed methods were successfully applied for the determination of metoprolol tartrate and hydrochlorothiazide in bulk powder and dosage form. The results obtained were analyzed statistically, and there was no significant difference between the 2 methods. The validation was performed according to International Conference on Harmonization guidelines.
Garg
Gopal
G
Pt. Ravishankar Shukla University, Institute of Pharmacy, Raipur, India.
Saraf
Shailendra
S
Saraf
Swarnlata
S
D000319:Adrenergic beta-Antagonists / Q000032:analysis*; D000959:Antihypertensive Agents / Q000032:analysis*; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D006852:Hydrochlorothiazide / Q000032:analysis*; D008790:Metoprolol / Q000032:analysis*; D011786:Quality Control; D012015:Reference Standards; D013607:Tablets
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D013607:Tablets; D006852:Hydrochlorothiazide; D008790:Metoprolol